Hemas Holdings PLC announced the appointment of Kasturi Chellaraja Wilson as Group Chief Executive Officer, effective October 1, 2020, succeeding Steven Enderby. As part of a planned succession, Kasturi will take on the role of Deputy CEO and be appointed to the Board of Hemas Holdings PLC, effective July 1.
Husein Esufally, Chairman, Hemas Holdings announced, “The Board decided to appoint Kasturi as Group CEO following a thorough selection process in line with our company’s succession plans, which prioritise developing internal talent. Kasturi is no stranger to Hemas, having been with us since 2002, and we are delighted that a long-standing colleague has risen to occupy the highest executive position in the Group.”
Commenting on the transition Esufally added, “Steven’s leadership over the last six years has enabled Hemas to become a more streamlined, purposeful and effective organization, which will stand us in good stead as we look to the future. Further, we are happy that Steven will continue to be associated with us as a member on the Boards of our Hotel ventures.”
“The future presents many exciting opportunities in Sri Lanka and in the Asian region, not only to scale our existing businesses, but also to expand into ‘new growth’ areas of Consumer, Healthcare and Mobility, which constitute our core verticals. Hemas’ revenues have doubled over the last five years, and we are certainly looking for a faster pace of growth in the years ahead,” said Esufally.
In a career spanning two decades at Hemas, Kasturi rose through the ranks to become the Chief Process Officer and thereafter in 2011 she took on the leadership of the aviation, travel and mobility businesses of the Group. In 2016, Kasturi was tasked with leading Hemas Pharmaceuticals.
Kasturi is a Fellow of the Chartered Institute of Management Accountants, UK. She has attended many leadership programmes over the span of her career, most notably the Senior Executive Leadership Program at Harvard Business School.
0 comments: